SCHEMBL17159642

SCHEMBL17159642

CC(C)[Si](OC[C@@H](OCc1ccccc1)[C@H](OCc1ccccc1)[C@@H](C=O)OCc1ccccc1)(C(C)C)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.36
CYP2C19 P33261 3/20 0.33
SLC1A3 P43003 2/20 0.33
SLC1A2 P43004 2/20 0.33
SLC1A1 P43005 2/20 0.33
CYP2C9 P11712 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP3A4 P08684 1/20 0.33
CTSB P07858 3/20 0.31
RCE1 Q9Y256 1/20 0.31
ADH1B P00325 1/20 0.30
ADH1C P00326 1/20 0.30
ADH1A P07327 1/20 0.30
ADH7 P40394 1/20 0.30
HTT P42858 1/20 0.30
CCNB2 O95067 1/20 0.30
CDK1 P06493 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17159638 1.00 MAPT (0.36) MAPTCYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL15652722 1.00 MAPT (0.36) MAPTCYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL17159578 0.88 MAPT (0.36) MAPTCYP2C19CYP2C9CYP3A4RCE1
SCHEMBL17159581 0.88 MAPT (0.36) MAPTCYP2C19CYP2C9CYP3A4RCE1
SCHEMBL17159580 0.88 MAPT (0.36) MAPTCYP2C19CYP2C9CYP3A4RCE1
SCHEMBL9304192 0.83 BTN3A1 (0.33) MAPTCYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL31074785 0.81 TSHR (0.40) MAPTCYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL17170474 0.80 CYP2C9 (0.39) MAPTCYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL17170481 0.80 CYP2C9 (0.39) MAPTCYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL17170399 0.80 CYP2C9 (0.39) MAPTCYP2C19SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9975911-B2 Antibacterial compounds and biological applications thereof MUTABILIS (FR) 2018-05-22 US disclosed
EP-2912043-B1 NEW ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF MUTABILIS (FR) 2016-11-30 EP disclosed
US-20150291636-A1 ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF LABORATOIRE BIODIM (FR) 2015-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291636-A1 ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF C3AR1, CFH, MSR1 MAPT 4880/4885CYP2C19 4557/4885SLC1A3 3566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.